Jarrow: FDA's talk of spiked supplements in context of NDI debate is 'highly disingenuous'
Food and Drug Administration (FDA) references to safety concerns over supplements spiked with drugs in the context of the debate on new dietary ingredients (NDIs) are “highly disingenuous”, Jarrow Formulas has argued.